Barclays PLC initiated coverage on shares of Medical Properties Trust Inc. (NYSE:MPW) in a research note issued to investors on Tuesday. The firm issued an equal weight rating and a $14.00 target price on the real estate investment trust’s stock.

Other equities analysts also recently issued research reports about the company. Zacks Investment Research upgraded Medical Properties Trust from a hold rating to a buy rating and set a $16.00 price objective on the stock in a report on Wednesday, September 21st. Stifel Nicolaus dropped their price objective on Medical Properties Trust from $16.00 to $13.00 and set a hold rating on the stock in a report on Monday, November 7th. Jefferies Group restated a hold rating and issued a $16.00 price objective on shares of Medical Properties Trust in a report on Thursday, November 3rd. JMP Securities reissued a hold rating on shares of Medical Properties Trust in a research report on Monday, October 3rd. Finally, Wells Fargo & Co. reaffirmed a hold rating on shares of Medical Properties Trust in a research report on Sunday, September 4th. Eight investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has an average rating of Hold and a consensus price target of $14.29.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Medical Properties Trust (NYSE:MPW) traded down 0.685% during trading on Tuesday, reaching $12.315. 648,447 shares of the company’s stock traded hands. The stock has a market capitalization of $3.03 billion, a P/E ratio of 12.439 and a beta of 0.91. The company has a 50-day moving average of $13.46 and a 200 day moving average of $14.58. Medical Properties Trust has a 12 month low of $9.61 and a 12 month high of $15.92.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, November 3rd. The real estate investment trust reported $0.30 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.30. The company had revenue of $126.60 million for the quarter, compared to the consensus estimate of $124.33 million. Medical Properties Trust had a return on equity of 10.03% and a net margin of 46.26%. The firm’s quarterly revenue was up 10.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.32 EPS. On average, equities research analysts expect that Medical Properties Trust will post $1.27 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 12th. Stockholders of record on Thursday, December 8th will be paid a $0.23 dividend. The ex-dividend date of this dividend is Tuesday, December 6th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 7.42%. Medical Properties Trust’s dividend payout ratio (DPR) is presently 93.88%.

Several hedge funds have recently made changes to their positions in the stock. Daiwa Securities Group Inc. raised its stake in shares of Medical Properties Trust by 1.2% in the second quarter. Daiwa Securities Group Inc. now owns 8,500 shares of the real estate investment trust’s stock worth $129,000 after buying an additional 100 shares during the period. MCF Advisors LLC raised its stake in shares of Medical Properties Trust by 1.5% in the third quarter. MCF Advisors LLC now owns 8,526 shares of the real estate investment trust’s stock worth $126,000 after buying an additional 129 shares during the period. Integrated Investment Consultants LLC raised its stake in shares of Medical Properties Trust by 1.4% in the third quarter. Integrated Investment Consultants LLC now owns 9,554 shares of the real estate investment trust’s stock worth $139,000 after buying an additional 130 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. raised its stake in shares of Medical Properties Trust by 0.4% in the third quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 39,099 shares of the real estate investment trust’s stock worth $577,000 after buying an additional 170 shares during the period. Finally, Keeley Asset Management Corp raised its stake in shares of Medical Properties Trust by 0.3% in the second quarter. Keeley Asset Management Corp now owns 73,658 shares of the real estate investment trust’s stock worth $1,120,000 after buying an additional 191 shares during the period. Institutional investors own 68.27% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Medical Properties Trust Inc. (MPW) Now Covered by Analysts at Barclays PLC” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright laws. The original version of this story can be accessed at https://www.thecerbatgem.com/2016/11/23/medical-properties-trust-inc-mpw-now-covered-by-analysts-at-barclays-plc.html.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust (REIT) focused on investing in and owning net-leased healthcare facilities. It conducts all of its business through MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases.

5 Day Chart for NYSE:MPW

Receive News & Stock Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related stocks with our FREE daily email newsletter.